# Evaluating the Clinical Efficacy of Resveratrol in Improving Metabolic and Skeletal Muscle Function in Patients With Heart Failure

> **NCT03525379** · PHASE2 · COMPLETED · sponsor: **University of Alberta** · enrollment: 13 (actual)

## Conditions studied

- Congestive Heart Failure Chronic

## Interventions

- **DRUG:** Resveratrol
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03525379
- **Lead sponsor:** University of Alberta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-26
- **Primary completion:** 2019-10-08
- **Final completion:** 2019-10-08
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03525379

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03525379, "Evaluating the Clinical Efficacy of Resveratrol in Improving Metabolic and Skeletal Muscle Function in Patients With Heart Failure". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03525379. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*